Back to top

AMA Statement on the ‘Skinny’ Bill in Senate Health Debate

For immediate release:
Jul 27, 2017
Back to top

Statement attributed to:
David O. Barbe, M.D.
President, American Medical Association

“Action is needed to address problems in the individual insurance market, but the so-called ‘skinny’ bill is a toxic prescription that would make matters worse. Eliminating the individual mandate will lead to adverse selection, triggering higher premiums and further destabilizing the individual market. The stated goal was to advance policies to lower premiums, but the ‘skinny’ bill would do the exact opposite, harming patients across the country. 

“Further, the bill would result in millions more Americans without health insurance coverage. 

“Again, we urge Senators to oppose the ‘skinny’ bill and to pivot to a bipartisan effort, working through appropriate committees of jurisdiction and regular order to fix problems and gaps in current law to enable Americans to obtain quality, affordable health insurance.”

###

Media Contact:
Jack Deutsch
AMA Media & Editorial
202-789-7442
[email protected]

About the American Medical Association
The American Medical Association is the premier national organization providing timely, essential resources to empower physicians, residents and medical students to succeed at every phase of their medical lives. Physicians have entrusted the AMA to advance the art and science of medicine and the betterment of public health on behalf of patients for more than 170 years. For more information, visit ama-assn.org.

Print this page Email this page